INVO Bioscience (NASDAQ:INVO) reported its Q2 earnings results on Monday, August 15, 2022 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
INVO Bioscience beat estimated earnings by 4.17%, reporting an EPS of $-0.23 versus an estimate of $-0.24.
Revenue was down $62 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 0.96% drop in the share price the next day.
Here’s a look at INVO Bioscience’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.25 | -0.22 | -0.20 | -0.19 |
| EPS Actual | -0.23 | 0.03 | -0.24 | -0.17 |
| Revenue Estimate | 240K | 210K | 330K | 410K |
| Revenue Actual | 162K | 3.05M | 218K | 208K |
To track all earnings releases for INVO Bioscience visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
